These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7879711)

  • 1. Comparison of various methods of lipopolysaccharide isolation from Coxiella burnetii strain Priscilla in the virulent phase I.
    Skultéty L; Toman R
    Acta Virol; 1994 Aug; 38(4):209-13. PubMed ID: 7879711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase variation of Coxiella burnetii strain Priscilla: influence of this phenomenon on biochemical features of its lipopolysaccharide.
    Ftácek P; Skultéty L; Toman R
    J Endotoxin Res; 2000; 6(5):369-76. PubMed ID: 11521057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the 3-deoxy-D-manno-2-octulosonic acid region in a lipopolysaccharide isolated from Coxiella burnetii strain Nine Mile in phase II.
    Toman R; Skultéty L
    Acta Virol; 1994 Aug; 38(4):241-3. PubMed ID: 7879717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved method of isolation of Coxiella burnetii proteins.
    Lukácová M; Kazár J
    Acta Virol; 1996 Feb; 40(1):55-8. PubMed ID: 8886100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the structural heterogeneity of the polysaccharide component of Coxiella burnetii strain Nine Mile lipopolysaccharide.
    Toman R; Kazár J
    Acta Virol; 1991 Nov; 35(6):531-7. PubMed ID: 1687636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase variation of lipopolysaccharide of Coxiella burnetii, strain Priscilla during chick embryo yolk sac passaging.
    Lukácová M; Kazár J; Gajdosová E; Vavreková M
    FEMS Microbiol Lett; 1993 Nov; 113(3):285-9. PubMed ID: 8270193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological consequences of Coxiella burnetii phase variation.
    Quevedo Diaz MA; Lukácová M
    Acta Virol; 1998 Jun; 42(3):181-5. PubMed ID: 9842448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic structural features of a lipopolysaccharide from the Coxiella burnetii strain Nine Mile in the virulent phase I.
    Toman R
    Acta Virol; 1992 Mar; 36(2):224. PubMed ID: 1359776
    [No Abstract]   [Full Text] [Related]  

  • 9. Further structural characteristics of the lipopolysaccharide from Coxiella burnetii strain nine mile in low virulent phase II.
    Toman R; Hussein A; Slabá K; Skultéty E
    Acta Virol; 2003; 47(2):129-30. PubMed ID: 14524481
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of phospholipids from Coxiella burnetii by fast atom bombardment mass spectrometry. A rapid method for differentiation of virulent phase I and low virulent phase II cells.
    Domingues P; Palkovic P; Toman R
    Acta Virol; 2002; 46(2):121-4. PubMed ID: 12387505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the determination of "Kdo-like substance" in the lipopolysaccharide from Coxiella burnetii strain nine mile in phase II.
    Toman R; Skultéty L; Kazár J
    Acta Virol; 1993; 37(2-3):196-8. PubMed ID: 8105667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and evaluation of Coxiella burnetii O-polysaccharide antigen as an immunodiagnostic reagent.
    Hussein A; Kovácová E; Toman R
    Acta Virol; 2001 Jun; 45(3):173-80. PubMed ID: 11774896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical characterization of the endotoxins from Coxiella burnetii strain Priscilla in relation to their bioactivities.
    Toman R; Garidel P; Andrä J; Slaba K; Hussein A; Koch MH; Brandenburg K
    BMC Biochem; 2004 Jan; 5():1. PubMed ID: 14715092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virulence of pathogenic Coxiella burnetii strains after growth in the absence of host cells.
    Kersh GJ; Oliver LD; Self JS; Fitzpatrick KA; Massung RF
    Vector Borne Zoonotic Dis; 2011 Nov; 11(11):1433-8. PubMed ID: 21867419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of proteins and lipopolysaccharides from Chinese isolates of Coxiella burnetii with monoclonal antibodies.
    Wen BH; Yu SR; Yu GQ; Li QJ; Zhang X
    Acta Virol; 1991 Nov; 35(6):538-44. PubMed ID: 1687637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional characterization of the glycan antigens involved in immunobiology of Q fever.
    Vadovic P; Slaba K; Fodorova M; Skultety L; Toman R
    Ann N Y Acad Sci; 2005 Dec; 1063():149-53. PubMed ID: 16481506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coxiella burnetii phase I and II proteins studied by SDS-page.
    Lukácová M; Kazár J; Gajdosová E
    Acta Virol; 1994 Oct; 38(5):263-7. PubMed ID: 7726000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody based differentiation of Coxiella burnetii isolates.
    Sekeyová Z; Thiele D; Krauss H; Karo M; Kazár J
    Acta Virol; 1996 Jun; 40(3):127-32. PubMed ID: 8891091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of virulence for guinea pigs and mice of different Coxiella burnetii phase I strains.
    Kazár J; Lesý M; Propper P; Valková D; Brezina R
    Acta Virol; 1993 Dec; 37(6):437-48. PubMed ID: 8010182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Entry of Coxiella burnetii into host cells.
    Baca OG; Klassen DA; Aragon AS
    Acta Virol; 1993; 37(2-3):143-55. PubMed ID: 8105658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.